Health Care [ 11/12 ] | Biotechnology [ 67/74 ]
NASDAQ | Common Stock
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia.
The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease.
It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease.
The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019.
Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 31, 23 | 0.00 Decreased by N/A% | - |
| Mar 2, 23 | 0.00 Decreased by N/A% | -1.80 Increased by +100.00% |
| Nov 30, 22 | 0.00 Decreased by N/A% | - |
| Aug 30, 22 | -0.24 Decreased by -77.14% | -0.24 |
| Jun 1, 22 | 0.00 Increased by +100.00% | - |
| Feb 28, 22 | 0.00 Increased by +100.00% | - |
| Dec 1, 21 | 0.00 Increased by +100.00% | - |
| Aug 30, 21 | -0.13 Decreased by -5.70 K% | -0.17 Increased by +22.35% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 2.12 M Increased by +N/A% | -12.62 M Decreased by N/A% | Decreased by -595.51% - |
| Mar 31, 24 | 690.72 K Decreased by -71.05% | -4.11 M Increased by +48.79% | Decreased by -595.51% Decreased by -76.89% |
| Dec 31, 23 | 1.90 M Increased by +149.12% | -6.51 M Decreased by -153.34% | Decreased by -342.35% Decreased by -1.69% |
| Jun 30, 23 | N/A Decreased by -100.00% | N/A Increased by +100.00% | - - |
| Mar 31, 23 | N/A Decreased by -100.00% | N/A Increased by +100.00% | - - |
| Dec 31, 22 | 2.39 M Increased by +178.37% | -8.03 M Decreased by -235.82% | Decreased by -336.65% Decreased by -20.64% |
| Sep 30, 22 | 762.98 K Decreased by -10.49% | -2.57 M Decreased by -7.98% | Decreased by -336.65% Decreased by -20.64% |
| Jun 30, 22 | 762.98 K Decreased by -17.15% | -2.57 M Decreased by -1.53% | Decreased by -336.65% Decreased by -22.55% |